ARCHIVES

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI To Invite Unaffiliated Oncologists To Enroll Patients On Phase III Trials

May 10, 2002

Funding opportunities listed.

May 7, 2004

DCBD Concepts Approved

November 8, 1985

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Patients Prefer Silicone Over Saline Implants

November 26, 2010

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 16, 1998